课题基金 / 基金详情

Molecular mechanism of immune-mediated marrow failure in paroxysmal nocturnal hemoglobinuria

Molecular mechanism of immune-mediated marrow failure in paroxysmal nocturnal hemoglobinuria
阵发性睡眠性血红蛋白尿症免疫介导骨髓衰竭的分子机制
批准号:
16590946
负责人:
KAWAGUCHI Tatsuya
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

KAWAGUCHI Tatsuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Paroxysmal nocturnal hemoglobinuria (PNH) and idiopathic aplastic anemia (AA) share immune-mediated bone marrow (BM) injury. However, the precise mechanism of the BM injury remains unknown. Recently, we showed that leukemic K562 cells were less sensitive to natural killer (NK) cell-mediated cytotoxicity in vitro when they acquired PIG-A mutations (Nagakura et al., Blood 2002 ; 100 : 1031-37). In the present study, we found that the decreased NK sensitivity of the leukemic cells was conferred by a deficiency of stress-inducible GPI-linked membrane UL16 binding proteins (ULBP) that activate NK and T cells, indicating that ULBP appeared on blood cells can intensify NK cell-mediated cytotoxicity in vitro. Of clinical interest, we found some PNH patients harboring ULBP-expressing (ULBP^+) blood cells. Thus, we expected that ULBP^+ cells could be injured by autologous cytotoxic effector cells (NK and CD8^+ T cells) expressing NKG2D, a receptor for ULBP. Actually, granulocytes of PNH patients carrying ULBP^+ granulocytes were shown to be susceptible to killing by autologous peripheral blood mononuclear cells including the effector cells. In contrast, the ULBP-associated killing was not observed in healthy donors nor PNH patients who had no ULBP^+ granulocytes. These results suggest that PNH patients undergo ULBP-associated marrow injury if they sustain pathogenic pressure to induce the stress proteins. We therefore conclude that the ULBP-NKG2D engagement is implicated in the pathogenesis of BM failure in a proportion of patients with BM failure syndromes and that the membrane expression of ULBP could be a useful clinical marker of immune-mediated marrow injury.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
発作性夜間ヘモグロビン尿症(PNH)診断の進歩と検査
阵发性睡眠性血红蛋白尿症(PNH)的诊断和检测进展
DOI: --
发表时间: 2006
期刊: 日本検査血液学会雑誌 7巻・1号(in press)
影响因子: --
作者: [川口辰哉, 花岡伸佳]
通讯作者: 花岡伸佳
Immunoselection by natural killer cells of PIG-A mutant cells missing stress-inducible ULBPs.
缺少应激诱导的 ULBP 的 PIG-A 突变细胞的自然杀伤细胞的免疫选择。
DOI: --
发表时间: 2006
期刊: Blood 107
影响因子: --
作者: [Nobuyoshi H, Kawaguchi T, Horikawa K, Nagakura S, Mitsuya H, Nakakuma H]
通讯作者: Nakakuma H
DOI: 10.1182/blood-2005-03-1337
发表时间: 2006-02-01
期刊: BLOOD
影响因子: 20.3
作者: [Hanaoka, N, Kawaguchi, T, Nakakuma, H]
通讯作者: Nakakuma, H
Development of the innovative laser technique for the micro-and nano-scale thermofluid phenomena
  • 批准号:
    20686014
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
  • 资助金额:
    $13.81万
  • 财政年份:
    2008
  • 负责人:
    KAWAGUCHI Tatsuya
  • 依托单位:
Clinical significance of NKG2D ligands as a pathognomonic marker for immune-mediated marrow injury in bone marrow failure syndromes
  • 批准号:
    19591119
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2007
  • 负责人:
    KAWAGUCHI Tatsuya
  • 依托单位:
MECHANISM FOR SELECTIVE EXPANSION OF A PIG-A MUTANT IN PAROXYSMAL NOCTURNAL HEMOGLOBINEMIA
  • 批准号:
    13671070
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.98万
  • 财政年份:
    2001
  • 负责人:
    KAWAGUCHI Tatsuya
  • 依托单位:
THE ETIOLOGY OF SOMATIC MUTATIONS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
  • 批准号:
    11671005
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $0.7万
  • 财政年份:
    1999
  • 负责人:
    KAWAGUCHI Tatsuya
  • 依托单位:
海外基金